WASHINGTON—The Food and Drug Administration issued a mandatory safety update today requiring manufacturers of popular GLP-1 weight loss medications to explicitly warn patients that the drugs can cause sudden, permanent vision loss, an announcement immediately met by millions of Americans squinting to read the fine print before placing another order.
The regulatory warning follows mounting data showing a correlation between the blockbuster appetite-suppressant injections and non-arteritic anterior ischemic optic neuropathy—more colloquially referred to as an "eye stroke." For an American public that has collectively agreed to treat internal organs like lease-to-own appliances in pursuit of a collarbone sharp enough to slice deli meat, the revelation of potential blindness was greeted not with alarm, but with the quiet, transactional calculus of a people who have long since abandoned the concept of bodily integrity.
"Sure, the brochure mentions a minor risk of plunging my optic nerve into an eternal abyss of void and shadow," said Chicago resident Marcus Vance, holding a pre-filled pen a mere centimeter from his dilated pupils. "But have you seen the engagement on my progress photos? I am down twenty-two pounds. I can see my own hip bones in the bathroom mirror, at least until the darkness takes over. That is a trade-off any rational person with a ring light would make."
Pharmaceutical executives rushed to reassure investors that the terrifying new side effect would likely boost, rather than dampen, consumer enthusiasm. Industry analysts noted that in a culture obsessed with aesthetic annihilation, the prospect of literally losing sight of one's own physical flaws is the ultimate wellness hack. Why worry about portion control when you can simply phase out the visual spectrum entirely?
"We are thrilled to comply with the FDA’s transparency mandates," said Novo Nordisk spokesperson Sarah Jenkins, speaking from behind a pair of heavily tinted designer sunglasses. "We want consumers to make informed choices. If those choices involve rolling the dice on total visual extinction so you can fit into a pair of vintage denim from 1998, who are we to stand in the way of human progress? Besides, if you can't see the scale, did you even gain weight?"
Medical professionals have attempted to sound the alarm, pointing out that trading your retinas for a diminished appetite represents a concerning philosophical shift in modern healthcare. Doctors report fielding anxious calls from patients asking if the blindness is localized to mirrors, or if they will still be able to gaze admiringly at their newly shrunken silhouettes in the dark.
"Patients are asking if they can choose which eye goes first, provided the remaining one stays focused on the thigh gap," said Dr. Aris Thorne, an endocrinologist in Boston. "They aren't negotiating terms. They are treating their eyeballs like disposable razor cartridges. We have built a society where being perceived as soft is treated as a terminal medical diagnosis, so naturally, a literal terminal medical diagnosis is being treated as an acceptable aesthetic tax."
As demand for the weekly injections continues to outstrip global supply, black market dealers have begun advertising discounted vials with the reassuring tagline: *Now with 40% more existential dread.* Consumers appear unfazed, lining up outside pharmacies with the grim, determined expressions of medieval peasants awaiting the plague, provided the plague results in a size-zero frame.
"If I have to choose between seeing the world clearly and never having to buy a larger pant size again, hand me the needle," Vance said, fumbling blindly for his injection site. "At least when I’m completely blind, I won't have to look at anyone eating pizza."
